105635-75-4 Usage
General Description
Ethocyn is a proprietary chemical compound developed by Chantal Pharmaceuticals that is designed to stimulate the production of elastin, a protein that helps maintain the elasticity and firmness of the skin. As people age, the production of elastin decreases, leading to the formation of wrinkles and sagging skin. Ethocyn works by targeting specific enzymes in the skin to increase elastin production, resulting in overall improvement in skin firmness and texture. It is often used in anti-aging skincare products and has been shown to have a positive impact on reducing the appearance of wrinkles and fine lines. However, the long-term effects and safety of this chemical compound are still in the process of being fully understood and researched.
Check Digit Verification of cas no
The CAS Registry Mumber 105635-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,6,3 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 105635-75:
(8*1)+(7*0)+(6*5)+(5*6)+(4*3)+(3*5)+(2*7)+(1*5)=114
114 % 10 = 4
So 105635-75-4 is a valid CAS Registry Number.
105635-75-4Relevant articles and documents
METHOD OF SYNTHESIS
-
, (2014/09/29)
Described is a method of synthesizing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0] octan-3-one by reacting 3-(5-ethoxyhept-1-yl) cyclopentene with dichloroketene. The resulting reaction products are reacted with acetic acid and zinc to produce 4-(5-ethoxyhept-1 -yl)bicyclo[3.2.0]heptan-6-one and 4-(5-ethoxyhept-1-yl)bicyclo [3.2.0]heptan-7-one, which are reacted with trimethylsulfonium iodide to produce 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane]. Lithium iodide is reacted with 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane] to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one. A method of synthesizing 6-(5-methoxyhept-1-yl)bicyclo[3.3.0]octan-3-one is also described.
